Secure Point Technologies Inc (fka IMSCQ)

[ktcougar]

Only one week left in October. Before long we'll be talking about DMRJ extending the March dead line.

Still remember this from Feb. 2013....

http://seekingalpha.com/article/1168151-investors-should-be-eyeing-implant-sciences-for-the-same-reasons-potential-acquirers-are

After much time and effort, Implant Sciences (OTCQB:IMSC) has successfully procured the most significant milestone in the company's existence. Shareholders and management have long anticipated a favorable outcome, but the Transportation Security Administration's (TSA) stamp of approval brings certitude to the use of Implant's explosive trace detection (ETD) technology in air cargo screening applications - and gives legs to a paramount market. Since jettisoning its semiconductor and medical businesses in 2007 and 2008, Implant has shifted its full focus to the development and commercialization of explosive trace detection, devices designed to pick up and alert security personnel to minute amounts of explosives or narcotics; think bomb-sniffing dogs but without the extensive oversight required by a K-9 unit. It's 2nd-generation technology, and Implant, with its small market capitalization and advanced, integrate-able technology, makes for a compelling play in the security space.

Last month, the company announced that the Department of Homeland Security's TSA approved the Quantum Sniffer B220, Implant's benchtop explosives and narcotics detection device, for use in U.S. air cargo screening. Considering that every piece of freight on passenger aircraft flying through U.S. airspace need to be screened for explosives - a requirement that only just went into effect - the approval lends more than just confidence; it's a significant opportunity for Implant as one of only three providers to make the list.

But more importantly, Implant is the only domestic ETD developer, which among other reasons, makes it both a compelling supplier for American customers and an ideal takeover target for other high-technology developers. And self-admittedly, Implant Sciences has already been approached about the technology. CEO Glenn D. Bolduc even alluded to licensing or buyout inquisitions on the company's recent earnings call: "We've actually been contacted by some very large companies in that regard. They recognize us as an independent company with a sole mission in explosive trace."

kt